18 filings
8-K
SONN
Sonnet BioTherapeutics Holdings Inc
27 Dec 19
Submission of Matters to a Vote of Security Holders
1:51pm
8-K
SONN
Sonnet BioTherapeutics Holdings Inc
14 Nov 19
Results of Operations and Financial Condition
4:10pm
8-K
SONN
Sonnet BioTherapeutics Holdings Inc
12 Nov 19
Regulation FD Disclosure
8:00am
8-K
SONN
Sonnet BioTherapeutics Holdings Inc
12 Nov 19
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
6:25am
8-K
SONN
Sonnet BioTherapeutics Holdings Inc
16 Oct 19
Regulation FD Disclosure
4:05pm
8-K
l5zvo4
11 Oct 19
Chanticleer Holdings Announces Merger Agreement with Sonnet BioTherapeutics to Advance Pipeline of Novel Immune Therapeutics
6:32am
8-K
2eq52 7wb1kl3u
11 Sep 19
Departure of Directors or Certain Officers
4:30pm
8-K
7os6a oefflktl
26 Aug 19
Departure of Directors or Certain Officers
5:00pm
8-K
z4bg0wxni 5u
19 Aug 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
neojdkmv0p gwt
14 Aug 19
Results of Operations and Financial Condition
12:00am
8-K
yj80pncgxmkvv
2 Jul 19
Chanticleer Holdings Announces Completion of Rights Offering for Gross Proceeds of $6.1M
5:18pm
8-K
awvg0 253nh5cs
25 Jun 19
Other Events
9:00am
8-K
8d1hk590oexyz4ge0cvh
20 May 19
Other Events
12:00am
8-K
45ssk7vqh7fq ruenb8
15 May 19
Results of Operations and Financial Condition
4:05pm
8-K
kkj6bi1
1 Apr 19
Reports Strong Unit and Footprint Growth, and the Addition of Proven Restaurant Executives to Enhance the Company’s Platform
4:15pm
8-K
6h3 64an1b5rrjafpj5e
25 Feb 19
Regulation FD Disclosure
8:30am
8-K
b7elic4qeva60w4
8 Jan 19
Chanticleer Holdings Names Patrick Harkleroad Chief Financial Officer
4:06pm
8-K
fk0jb4 62
4 Jan 19
Entry into a Material Definitive Agreement
6:15am
- Prev
- 1
- Next